Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03226418
Title Cytarabine, Idarubicin, Liposome-encapsulated Daunorubicin-Cytarabine or Decitabine in Treating Older Patients With Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Nebraska
Indications

acute myeloid leukemia

Therapies

Cytarabine

Decitabine + Venetoclax

Azacitidine + Venetoclax

CPX-351

Cytarabine + Idarubicin

Azacitidine + Glasdegib

Decitabine + Glasdegib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Nebraska Medical Center Recruiting Omaha Nebraska 68198 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field